Emcure Pharmaceuticals Ltd.
EMCURE
Kedudukan dalam Saham
#4315
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Harga Saham
$18.94
Modal Pasaran
$3.59B
Perubahan (1 hari)
-2.44%
Perubahan (1 tahun)
19.75%
Negara
IN
Perdagangan Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Sejarah hasil dividen untuk Emcure Pharmaceuticals Ltd. (EMCURE)
Hasil dividen (TTM) bagi Emcure Pharmaceuticals Ltd. (simbol saham: EMCURE) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Emcure Pharmaceuticals Ltd. (EMCURE) dari 2025 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Ubah |
|---|---|---|
| 2025 | 0.00% | 0.00% |
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
| Syarikat | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
